November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Full results and Plain Language Summary for CheckMate 77T trial – NEJM
May 28, 2024, 07:48

Full results and Plain Language Summary for CheckMate 77T trial – NEJM

NEJM shared on X/Twitter:

“In the CheckMate 77T trial, researchers assessed whether adding adjuvant nivolumab to neoadjuvant nivolumab plus chemotherapy would improve outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Full results and Plain Language Summary.”

Perioperative Nivolumab in Resectable Lung Cancer A PLAIN LANGUAGE SUMMARY Top Figure: Illustration of treatment options during the Neoadjuvant and Adjuvant Periods. Bottom Figure: Graph of the Percentage of Patients with Event-free Survival

Source: NEJM/X